Open AccessEnfortumab Vedotin (Padcev)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.343
Subject(s) - reimbursement , medicine , urothelial cancer , drug , anticancer drug , oncology , cancer , pharmacology , political science , health care , bladder cancer , law